HYDERABAD: Dr Reddy's Laboratories Limited on Tuesday announced that it has launched Levetiracetam in Sodium Chloride Injection in the US Market.
Levetiracetam in Sodium Chloride Injection is a therapeutic equivalent generic version of HQ Specialty Pharma Corporation and was approved by the US Food and Drug Administration (USFDA), a statement here said.
The Levetiracetam in Sodium Chloride Injection brand and generic had US sales of approximately USD 37 million MAT for the most recent twelve months ending in April 2018 according to IMS Health.
Dr Reddy's Levetiracetam in Sodium Chloride Injection is available in strengths of 500 mg/100 mL (5 mg/mL), 1,000 mg/100 mL (10 mg/mL), and 1,500 mg/100 mL (15 mg/mL) single-dose infusion bags, the statement added.